Research & Publications
Nauder Faraday, MD, MPH
Research & Publications
Whether in the lab, clinic, or collaborating with industry, Dr. Faraday has spearheaded innovations that advanced the field and influenced best practices.
He has conducted laboratory and clinical cardiovascular research for more than three decades, having received continuous funding as a PI or Co-I from the NIH, NSF, American Heart Association, and state and corporate sponsors. His research work has involved a variety of techniques, including in vitro laboratory assays, animal disease models, multi-omics association approaches, and human clinical trials.
His research has focused on identifying the molecular and genetic basis for inter-individual variability in platelet function and response to anti-platelet therapy, and identifying the molecular mechanisms through which neutrophil-platelet interactions promote vascular thrombosis and resistance to aspirin treatment. His clinical research has focused on identification of novel risk factors and mechanisms for cardiovascular, thrombotic/bleeding, kidney, and infectious complications after surgery.
His recent research has focused on use of statistical and machine learning approaches that leverage electronic health record data to develop models to predict and diagnose complications such as:
myocardial injury,
acute kidney injury, and
hospital/ICU readmission of acutely ill patients.
The overarching goal of his research is to identify novel determinants of organ injury, facilitating a precision guided approach to prevent, diagnose, and treat disease of vital organs.
Dr. Faraday’s research accomplishments include:
90 Peer-Reviewed Original Science Publications.
4 review articles, 8 Editorials/Letters, and 7 Book Chapters/Monographs.
PI/ Co-I on 14 grant awards from the NIH, NSF, AHA.
Editorial Board appointments to Anesthesiology and Thrombosis & Hemostasis: Research.
Named by Anesthesiology, the official journal of the American Society of Anesthesiologists, as a Top 10% reviewer.
Ad hoc reviewer for 28 different peer-review journals.
Intellectual Property and Collaborations with Industry
Inventions, Patents, Copyrights:
12/23/04: US patent 2004/0260058-A1: Novel endothelially expressed DNAs and proteins, and their use.
1/13/11: US patent 12/665,859: Novel antithrombotic agents and their methods of use.
1/18/25: US Patent 63/622,315: Intraoperative monitor of aggregate organ injury.
Dr. Faraday served as a consultant for CSL Behring from 2014 - 2016.